Cargando…
Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels
This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior.
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644257/ https://www.ncbi.nlm.nih.gov/pubmed/36346635 http://dx.doi.org/10.1001/jamanetworkopen.2022.40513 |
_version_ | 1784826703559786496 |
---|---|
author | O’Neil, Adam Calderbank, Steve Brown, James Vandigo, Joe Yin, Perry Bratti, Keith Howell, Scott |
author_facet | O’Neil, Adam Calderbank, Steve Brown, James Vandigo, Joe Yin, Perry Bratti, Keith Howell, Scott |
author_sort | O’Neil, Adam |
collection | PubMed |
description | This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior. |
format | Online Article Text |
id | pubmed-9644257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-96442572022-11-28 Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels O’Neil, Adam Calderbank, Steve Brown, James Vandigo, Joe Yin, Perry Bratti, Keith Howell, Scott JAMA Netw Open Research Letter This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior. American Medical Association 2022-11-08 /pmc/articles/PMC9644257/ /pubmed/36346635 http://dx.doi.org/10.1001/jamanetworkopen.2022.40513 Text en Copyright 2022 O’Neil A et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License. |
spellingShingle | Research Letter O’Neil, Adam Calderbank, Steve Brown, James Vandigo, Joe Yin, Perry Bratti, Keith Howell, Scott Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels |
title | Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels |
title_full | Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels |
title_fullStr | Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels |
title_full_unstemmed | Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels |
title_short | Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels |
title_sort | quantification of utilization management barriers for patients initiating therapy to lower lipid levels |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644257/ https://www.ncbi.nlm.nih.gov/pubmed/36346635 http://dx.doi.org/10.1001/jamanetworkopen.2022.40513 |
work_keys_str_mv | AT oneiladam quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels AT calderbanksteve quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels AT brownjames quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels AT vandigojoe quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels AT yinperry quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels AT brattikeith quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels AT howellscott quantificationofutilizationmanagementbarriersforpatientsinitiatingtherapytolowerlipidlevels |